News
The research established patient-derived ovarian cancer organoid models to assess TQB3616, a CDK4/6 inhibitor, efficacy. RNA sequencing and analyses identified TRIM4 as a key gene correlating with ...
The research established patient-derived ovarian cancer organoid models to assess TQB3616, a CDK4/6 inhibitor, efficacy. RNA sequencing and analyses identified TRIM4 as a key gene correlating with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback